Exclusive to Church Pharmacy

The Range

YVOIRE® is a small but mighty product range comprised of four HA dermal fillers. The range of YVOIRE® products allows healthcare professionals to meet the specific needs of their patients.

Mesoline Antiox

Fine to moderate wrinkle correction. Includes 0.3% lidocaine.

Shop now

YVOIRE® Volume Plus

Deep wrinkle correction & volumising. Includes 0.3% lidocaine.

Shop now

YVOIRE® Contour

Definition & projection

Shop now

YVOIRE® Y-Solution 720

Fine to deep wrinkle correction. Volumisation and definition. Includes 0.3% lidocaine.

Shop now

Who are LG Chem?

LG Chem are a leading chemical company in Korea. Starting from basic materials and chemical business to energy solutions, IT and electricals, they expanded into Life Sciences. Constantly strengthening its research and development, LG Chem has received U.S. FDA approval for its new drugs for the first time in Korea.

LG Chem also has a long history in aesthetics, developing and manufacturing hyaluronic acid in pharmaceutical products for over 30 years. From this LG Chem launched the first Korean hyaluronic acid filler, YVOIRE^®. LG Chem are one of few companies that have full control over the quantity and safety of the product, from the raw HA material to the end product.

With countless growth, research and development LG Chem have provided the aesthetics industry with a safe, affordable and reliable filler brand.

About YVOIRE®

YVOIRE^® is a hyaluronic acid filler that is made from non-animal substances and has been approved and certified for its safety. Its high molecular weight HA has been approved by the European Directorate for the Quality of Medicines and US FDA filed.

YVOIRE^®uses HICE^™cross-linking technology, which provides endless benefits.

YVOIRE^® has sold over 25 million syringes in 40 countries over 25 years, there has also been over 10 million YVOIRE^® injections carried out globally.

HICE™ Cross-linking Technology

HICE™ (High Concentration Equalized) cross-linking technology reaches a maximum cross-linking ratio with the minimal use of BDDE by dispersing them into highly concentrated HA.